Source: United States Census Bureau [1]. NYS: New York State
Declarations
Author contributions
AJM: Investigation, Data curation, Writing—original draft, Writing—review & editing. TS: Formal analysis, Validation, Writing—review & editing. DP: Conceptualization, Formal analysis, Resources. AV: Writing—review & editing, Validation. MD: Formal analysis, Writing—review & editing. KA: Conceptualization, Investigation, Writing—review & editing, Project administration, Resources, Supervision. All authors read and approved the submitted version.
Conflicts of interest
Margaret DeAngelis who is the Associate Editor of Exploration of Medicine had no involvement in the decision-making or the review process of this manuscript. The other authors declare that there are no conflicts of interest.
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Consent to publication
Not applicable.
Availability of data and materials
Publicly available datasets from Vision and Eye Health Surveillance System (VEHSS), United States Census Bureau, University of Wisconsin Population Health Institute, the United States Department of Agriculture, and Economic Research Service.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Census Bureau Data. Explore Census Data [Internet].[cited 2023 Apr 29]. Available from: https://data.census.gov/
Klein BEK. Overview of epidemiologic studies of diabetic retinopathy.Ophthalmic Epidemiol. 2007;14:179–83. [DOI] [PubMed]
Morello CM. Etiology and natural history of diabetic retinopathy: an overview.Am J Health Syst Pharm. 2007;64:S3–7. [DOI] [PubMed]
Duh EJ, Sun JK, Stitt AW. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.JCI Insight. 2017;2:e93751. [DOI] [PubMed] [PMC]
Barsegian A, Kotlyar B, Lee J, Salifu MO, McFarlane SI. Diabetic Retinopathy: Focus on Minority Populations.Int J Clin Endocrinol Metab. 2017;3:34–45. [DOI] [PubMed] [PMC]
Fairless E, Nwanyanwu K. Barriers to and Facilitators of Diabetic Retinopathy Screening Utilization in a High-Risk Population.J Racial Ethn Health Disparities. 2019;6:1244–9. [DOI] [PubMed] [PMC]
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.Diabetes Care. 2004;27:1047–53. [DOI] [PubMed]
Coney JM, Scott AW. Racial disparities in the screening and treatment of diabetic retinopathy.J Natl Med Assoc. 2022;114:171–81. [DOI] [PubMed]
Muñoz B, West SK, Rubin GS, Schein OD, Quigley HA, Bressler SB, et al. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study.Arch Ophthalmol. 2000;118:819–25. [DOI] [PubMed]
Muñoz B, O’Leary M, Fonseca-Becker F, Rosario E, Burguess I, Aguilar M, et al. Knowledge of diabetic eye disease and vision care guidelines among Hispanic individuals in Baltimore with and without diabetes.Arch Ophthalmol. 2008;126:968–74. [DOI] [PubMed] [PMC]
Lamoureux EL, Hassell JB, Keeffe JE. The impact of diabetic retinopathy on participation in daily living.Arch Ophthalmol. 2004;122:84–8. [DOI] [PubMed]
Anderson RM, Wolf FM, Musch DC, Fitzgerald JT, Johnson MW, Nwankwo RB, et al. Conducting community-based, culturally specific, eye disease screening clinics for urban African Americans with diabetes.Ethn Dis. 2002;12:404–10. [PubMed]
Coyne KS, Margolis MK, Kennedy-Martin T, Baker TM, Klein R, Paul MD, et al. The impact of diabetic retinopathy: perspectives from patient focus groups.Fam Pract. 2004;21:447–53. [DOI] [PubMed]
Varma R, Torres M, Peña F, Klein R, Azen SP; Los Angeles Latino Eye Study Group. Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study.Ophthalmology. 2004;111:1298–306. [DOI] [PubMed]
West SK, Klein R, Rodriguez J, Muñoz B, Broman AT, Sanchez R, et al. Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER.Diabetes Care. 2001;24:1204–9. [DOI] [PubMed]
Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis.Ophthalmology. 2014;121:2081–90. [DOI] [PubMed]
Allison K, Patel D, Alabi O. Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future.Cureus. 2020;12:e11686. [DOI] [PubMed] [PMC]
Friedman DS, Wolfs RC, O’Colmain BJ, Klein BE, Taylor HR, West S, et al.; Eye Diseases Prevalence Research Group. Prevalence of open-angle glaucoma among adults in the United States.Arch Ophthalmol. 2004;122:532–8. [DOI] [PubMed] [PMC]
Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt JC, et al. Racial differences in the cause-specific prevalence of blindness in east Baltimore.N Engl J Med. 1991;325:1412–7. [DOI] [PubMed]
Haymes SA, Leston JD, Ferucci ED, Etzel RA, Lanier AP. Visual impairment and eye care among Alaska Native people.Ophthalmic Epidemiol. 2009;16:163–74. [DOI] [PubMed] [PMC]
Lee ET, Russell D, Morris T, Warn A, Kingsley R, Ogola G. Visual impairment and eye abnormalities in Oklahoma Indians.Arch Ophthalmol. 2005;123:1699–704. [DOI] [PubMed]
Greenberg PB, Tseng VL, Wu WC, Liu J, Jiang L, Chen CK, et al. Prevalence and predictors of ocular complications associated with cataract surgery in United States veterans.Ophthalmology. 2011;118:507–14. [DOI] [PubMed]
Liu YC, Wilkins M, Kim T, Malyugin B, Mehta JS. Cataracts.Lancet. 2017;390:600–12. [DOI] [PubMed]
Khairallah M, Kahloun R, Bourne R, Limburg H, Flaxman SR, Jonas JB, et al.; Vision Loss Expert Group of the Global Burden of Disease Study. Number of People Blind or Visually Impaired by Cataract Worldwide and in World Regions, 1990 to 2010.Invest Ophthalmol Vis Sci. 2015;56:6762–9. [DOI] [PubMed]
Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010.Br J Ophthalmol. 2012;96:614–8. [DOI] [PubMed]
Fang R, Yu YF, Li EJ, Lv NX, Liu ZC, Zhou HG, et al. Global, regional, national burden and gender disparity of cataract: findings from the global burden of disease study 2019.BMC Public Health. 2022;22:2068. [DOI] [PubMed] [PMC]
Gedde SJ, Feuer WJ, Crane AM, Shi W. Factors Influencing Career Decisions and Satisfaction Among Newly Practicing Ophthalmologists.Am J Ophthalmol. 2022;234:285–326. [DOI] [PubMed]
Nsiah-Kumi P, Ortmeier SR, Brown AE. Disparities in diabetic retinopathy screening and disease for racial and ethnic minority populations—a literature review.J Natl Med Assoc. 2009;101:430–7. [DOI] [PubMed]
Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy.Ann Intern Med. 1996;124:164–9. [DOI] [PubMed]
The Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study Report no. 4.Int Ophthalmol Clin. 1987;27:265–72. [DOI] [PubMed]
The Diabetic Retinopathy Study Research Group. Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study.Arch Ophthalmol. 1979;97:654–5. [DOI] [PubMed]
Kempen JH, O’Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, et al.; Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States.Arch Ophthalmol. 2004;122:552–63. [DOI] [PubMed]
Leske MC, Wu SY, Hyman L, Li X, Hennis A, Connell AM, et al. Diabetic retinopathy in a black population: the Barbados Eye Study.Ophthalmology. 1999;106:1893–9. [DOI] [PubMed]
Klein R, Klein BE, Moss SE, Linton KL. The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus.Ophthalmology. 1992;99:58–62. [DOI] [PubMed]
Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XV. The long-term incidence of macular edema.Ophthalmology. 1995;102:7–16. [DOI] [PubMed]
Emanuele N, Moritz T, Klein R, Davis MD, Glander K, Khanna A, et al.; Veterans Affairs Diabetes Trial Study Group. Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT).Diabetes Res Clin Pract. 2009;86:104–10. [DOI] [PubMed]
Paz SH, Varma R, Klein R, Wu J, Azen SP; Los Angeles Latino Eye Study Group. Noncompliance with vision care guidelines in Latinos with type 2 diabetes mellitus: the Los Angeles Latino Eye Study.Ophthalmology. 2006;113:1372–7. [DOI] [PubMed]
American Diabetes Association. Diabetic Retinopathy.Diabetes Care. 2002;25:s90–3. [DOI]
Moss SE, Klein R, Klein BE. Factors associated with having eye examinations in persons with diabetes.Arch Fam Med. 1995;4:529–34. [DOI] [PubMed]
Walker EA, Basch CE, Howard CJ, Zybert PA, Kromholz WN, Shamoon H. Incentives and barriers to retinopathy screening among African-Americans with diabetes.J Diabetes Complications. 1997;11:298–306. [DOI] [PubMed]
Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al.; Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy.Diabetes Care. 2012;35:556–64. [DOI] [PubMed] [PMC]
Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, McCarty DJ, et al.; AusDiab Study Group. The prevalence of and factors associated with diabetic retinopathy in the Australian population.Diabetes Care. 2003;26:1731–7. [DOI] [PubMed]
Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008.JAMA. 2010;304:649–56. [DOI] [PubMed] [PMC]
Roy MS. Diabetic retinopathy in African Americans with type 1 diabetes: The New Jersey 725: II. Risk factors.Arch Ophthalmol. 2000;118:105–15. [DOI] [PubMed]
Hartnett ME, Key IJ, Loyacano NM, Horswell RL, Desalvo KB. Perceived barriers to diabetic eye care: qualitative study of patients and physicians.Arch Ophthalmol. 2005;123:387–91. [DOI] [PubMed]
Anderson S, Broadbent DM, Swain JYS, Vora JP, Harding SP. Ambulatory photographic screening for diabetic retinopathy in nursing homes.Eye (Lond). 2003;17:711–6. [DOI] [PubMed]
Betancourt JR, Green AR, Carrillo JE, Park ER. Cultural competence and health care disparities: key perspectives and trends.Health Aff (Millwood). 2005;24:499–505. [DOI] [PubMed]
Gorman CA, Zimmerman BR, Smith SA, Dinneen SF, Knudsen JB, Holm D, et al. DEMS — a second generation diabetes electronic management system.Comput Methods Programs Biomed. 2000;62:127–40. [DOI] [PubMed]
Liu J, Gibson E, Ramchal S, Shankar V, Piggott K, Sychev Y, et al. Diabetic Retinopathy Screening with Automated Retinal Image Analysis in a Primary Care Setting Improves Adherence to Ophthalmic Care.Ophthalmol Retina. 2021;5:71–7. [DOI] [PubMed] [PMC]
Jani PD, Forbes L, Choudhury A, Preisser JS, Viera AJ, Garg S. Evaluation of Diabetic Retinal Screening and Factors for Ophthalmology Referral in a Telemedicine Network.JAMA Ophthalmol. 2017;135:706–14. [DOI] [PubMed] [PMC]
Iskander M, Hu G, Coulon S, Seixas AA, McGowan R, Al-Aswad LA. Health literacy and ophthalmology: A scoping review.Surv Ophthalmol. 2023;68:78–103. [DOI] [PubMed]
Elam AR, Lee PP. High-risk populations for vision loss and eye care underutilization: a review of the literature and ideas on moving forward.Surv Ophthalmol. 2013;58:348–58. [DOI] [PubMed]
Ackland P, Resnikoff S, Bourne R. World blindness and visual impairment: despite many successes, the problem is growing.Community Eye Health. 2017;30:71–3. [PubMed] [PMC]
